William Johnson, MD
Ophthalmology · Greenville, SCNPI 1942689690
Payments from drug & device makers
What this record shows
Bausch & Lomb Americas Inc. accounts for 69.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,170 and has fallen 95.5% since, to $53 in 2025. That places this record below the midpoint for ophthalmology clinicians in SC, where the typical reported total is $1,895.
Across 23 payments — averaging $82.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$1K
- Dutch Ophthalmic, USA$139
- Apellis Pharmaceuticals, Inc.$128
- Omeros Corporation$118
- Alcon$77
- Glaukos Corporation$36
- plus $88 from 3 others
What the payments were for
- Travel & lodging$97852%
- Food & beverage$91748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 10 | $1,309 |
| Dutch Ophthalmic, USA | 2 | $139 |
| Apellis Pharmaceuticals, Inc. | 1 | $128 |
| Omeros Corporation | 1 | $118 |
| Alcon | 3 | $77 |
| Glaukos Corporation | 2 | $36 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $31 |
| Astellas Pharma US Inc | 2 | $30 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$978
- Syfovre$128
- EVA, combined machine$127
- TISSUEBLUE$127
- OMIDRIA$118
- XIPERE$117
How this compares
$1,895 in reported general payments places this provider in the 50th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 35 | $1,598 |
| Ofloxacin | 14 | $149 |
| ErythromycinErythromycin Base | 11 | $121 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Greenville
- Alan LeaheyGreenville$35K
- William BallingerGreenville$14K
- Dilip ThomasGreenville$8K
- Brian WelcomeGreenville$7K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Erik HappMt Pleasant$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.